X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1345) 1345
hiv infections - drug therapy (1046) 1046
stavudine - therapeutic use (855) 855
anti-hiv agents - therapeutic use (802) 802
male (785) 785
female (763) 763
adult (693) 693
stavudine (632) 632
infectious diseases (622) 622
drug therapy, combination (451) 451
reverse transcriptase inhibitors - therapeutic use (433) 433
hiv (425) 425
lamivudine - therapeutic use (407) 407
index medicus (400) 400
middle aged (398) 398
immunology (354) 354
virology (329) 329
zidovudine - therapeutic use (328) 328
antiretroviral therapy (317) 317
viral load (306) 306
cd4 lymphocyte count (302) 302
stavudine - adverse effects (296) 296
anti-hiv agents - adverse effects (294) 294
hiv infections - virology (292) 292
pharmacology & pharmacy (289) 289
lamivudine (277) 277
zidovudine (275) 275
stavudine - administration & dosage (246) 246
aids (231) 231
didanosine - therapeutic use (229) 229
hiv-1 - drug effects (226) 226
treatment outcome (223) 223
hiv infection (214) 214
hiv protease inhibitors - therapeutic use (213) 213
therapy (203) 203
nevirapine - therapeutic use (202) 202
drug therapy (198) 198
antiretroviral therapy, highly active (195) 195
highly active antiretroviral therapy (194) 194
anti-hiv agents - administration & dosage (191) 191
antiviral agents (184) 184
hiv-1 - genetics (176) 176
hiv infections - complications (170) 170
human-immunodeficiency-virus (169) 169
nevirapine (159) 159
protease inhibitors (158) 158
hiv infections - immunology (157) 157
reverse transcriptase inhibitors - adverse effects (153) 153
adolescent (144) 144
microbiology (142) 142
research (142) 142
tenofovir (140) 140
rna, viral - blood (139) 139
child (138) 138
anti-hiv agents - pharmacology (136) 136
hiv-1 (135) 135
human immunodeficiency virus--hiv (135) 135
antiretroviral drugs (134) 134
didanosine (134) 134
lamivudine - administration & dosage (132) 132
risk factors (126) 126
stavudine - pharmacology (125) 125
reverse transcriptase inhibitors - administration & dosage (121) 121
health aspects (120) 120
acquired immunodeficiency syndrome - drug therapy (117) 117
cohort studies (114) 114
prospective studies (113) 113
indinavir - therapeutic use (107) 107
hiv patients (106) 106
care and treatment (105) 105
retrospective studies (105) 105
efavirenz (103) 103
lipodystrophy (101) 101
mutation (101) 101
ritonavir - therapeutic use (100) 100
hiv-infected patients (99) 99
infection (99) 99
aged (97) 97
human immunodeficiency virus (96) 96
reverse-transcriptase inhibitors (95) 95
active antiretroviral therapy (94) 94
dideoxynucleosides - therapeutic use (94) 94
lamivudine - adverse effects (94) 94
time factors (93) 93
toxicity (93) 93
anti-hiv agents - pharmacokinetics (92) 92
child, preschool (91) 91
acquired immune deficiency syndrome--aids (90) 90
research article (90) 90
pharmacokinetics (88) 88
drug resistance (86) 86
hiv infections - blood (86) 86
reverse transcriptase inhibitors - pharmacology (86) 86
zidovudine - adverse effects (86) 86
adenine - analogs & derivatives (85) 85
analysis (85) 85
drug administration schedule (83) 83
antiretroviral therapy, highly active - adverse effects (82) 82
zidovudine - administration & dosage (82) 82
adults (80) 80
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1466) 1466
French (23) 23
Spanish (13) 13
German (10) 10
Chinese (8) 8
Italian (3) 3
Dutch (2) 2
Danish (1) 1
Japanese (1) 1
Polish (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2008, Volume 358, Issue 20, pp. 2095 - 2106
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2002, Volume 346, Issue 26, pp. 2039 - 2046
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 05/2007, Volume 45, Issue 1, pp. 34 - 42
BACKGROUND:The effects of HIV infection, highly active antiretroviral therapy (HAART), and specific antiretroviral agents on lipoproteins in women are not well... 
Low-density lipoprotein | Women | Highly active antiretroviral therapy | Lipids | High-density lipoprotein | INFECTIOUS DISEASES | lipids | high-density lipoprotein | BODY-COMPOSITION | IMMUNOLOGY | INSULIN SENSITIVITY | PROTEASE INHIBITORS | low-density lipoprotein | DIABETES-MELLITUS | NAIVE SUBJECTS | DENSITY-LIPOPROTEIN CHOLESTEROL | THERAPY | PLASMA-CONCENTRATIONS | highly active antiretroviral therapy | INFECTED PATIENTS | LOPINAVIR/RITONAVIR | women | Cholesterol - blood | Didanosine - adverse effects | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Hispanic Americans - statistics & numerical data | Nevirapine - adverse effects | Tenofovir | Adenine - therapeutic use | Stavudine - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Dideoxynucleosides - adverse effects | HIV Protease Inhibitors - adverse effects | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Organophosphonates - adverse effects | HIV Protease Inhibitors - therapeutic use | HIV-1 | Didanosine - therapeutic use | Multivariate Analysis | Lipoproteins, HDL - blood | United States | HIV Seropositivity - drug therapy | Nevirapine - therapeutic use | Lamivudine - adverse effects | Adenine - adverse effects | Ritonavir - adverse effects | Stavudine - adverse effects | Lipids - blood | Adult | Anti-HIV Agents - therapeutic use | Female | Dideoxynucleosides - therapeutic use | Drug Therapy, Combination | HIV Seronegativity | Nelfinavir - therapeutic use | Fasting | Cross-Sectional Studies | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | European Continental Ancestry Group - statistics & numerical data | Benzoxazines - therapeutic use | Nelfinavir - adverse effects | African Continental Ancestry Group - statistics & numerical data | Triglycerides - blood | HIV Infections - drug therapy | Indinavir - adverse effects | Lipoproteins, LDL - blood | HIV Infections - metabolism | Indinavir - therapeutic use | Measurement | Complications and side effects | Dosage and administration | Blood lipids | Health aspects | HIV infection
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 2/2014, Volume 209, Issue 3, pp. 399 - 408
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, p. e0178942
Introduction Antiretroviral therapy (ART) has been successfully introduced in low-middle income countries. However an increasing rate of ART failure with... 
VIRAL LOAD | AFRICA | VIROLOGICAL FAILURE | PERFORMANCE | MULTIDISCIPLINARY SCIENCES | ADULTS | SWITCH | CHILDREN | Humans | Male | Nevirapine - therapeutic use | Monitoring, Physiologic | HIV-1 - growth & development | Clinical Decision-Making | Stavudine - therapeutic use | Treatment Failure | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | pol Gene Products, Human Immunodeficiency Virus - genetics | Emtricitabine - therapeutic use | Cross-Sectional Studies | Tenofovir - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Computational Biology | Tanzania | Genotype | HIV-1 - genetics | Benzoxazines - therapeutic use | HIV-1 - classification | Antiretroviral Therapy, Highly Active | Atazanavir Sulfate - therapeutic use | Drug Resistance, Viral - genetics | HIV Infections - drug therapy | Lopinavir - therapeutic use | Viral Load - drug effects | Prevention | Antiviral agents | Care and treatment | Analysis | DNA polymerases | Dosage and administration | Research | Drug resistance | Drug therapy | HIV infection | Drugs | Therapy | Load distribution | RNA-directed DNA polymerase | Nevirapine | Cross-resistance | Medical services | Switches | Income | Viruses | Stavudine | Criteria | Efavirenz | Accumulation | Guidelines | Gene sequencing | Fragmentation | Tenofovir | Disease resistance | Immunology | Salvage | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Bioinformatics | Monitoring | Failure | Deoxyribonucleic acid--DNA | Emtricitabine | Antiretroviral drugs | Sensitivity analysis | Lopinavir | Lamivudine | Antiretroviral therapy | Amplification | Sensitivity | Algorithms | Inhibitors | Genotyping | Abacavir | Mutation | DNA sequencing | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | HIV | DNA | Human immunodeficiency virus
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 02/2008, Volume 47, Issue 2, pp. 161 - 167
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 3, pp. 296 - 304
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9707, pp. 2080 - 2089
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2017, Volume 12, Issue 8, p. e0183080
Journal Article